LRVHealth

Earlier this month, Ellen Herlacher joined Andrea Linna for a session on executive leadership in venture-backed digital health companies at #DHISEast in Boston.    They covered a lot of ground during the discussion, hitting on topics ranging from the dynamics of a founding team and how they complement each other (or don’t), to the need for everyone in the industry to challenge the stereotypes of a good founder. The truth is, exceptional founders come in all ages, races, genders and personalities, and having diverse perspectives will significantly strengthen the system overall.     Here's a quick recap compliments of Kristin Parran Faulder – thanks for the writeup!  https://lnkd.in/etXpd-33 

LRVHealth’s Christiana DelloRusso moderated a panel on #womenshealth last month at MedCity News INVEST. She was joined by Melissa Dennis MD MHA FACOG of Partum Health, Joe Connolly of Visana Health, and Melissa Rabin Lederer of mHUB . The group noted that the funding landscape for women’s health companies is getting better, partially due to more women getting promoted at VC firms.   Check out this MedCity News article by Marissa Plescia for more details on how women’s health conversations with investors have evolved. https://lnkd.in/gcz6XXvj

We are excited to have Humata Health join the LRVHealth family! Congratulations to Jeremy Friese, MD and the entire Humata Health team for closing a $25M investment. We led this investment alongside The Blue Venture Fund with participation from Optum Ventures, .406 Ventures, and Highmark Health Ventures. We are thrilled to be part of this group of strategic investors to accelerate the expansion of Humata’s AI-driven prior authorization solutions and expand its customer base. Humata Health’s platform offers a scalable, automated, end-to-end solution that not only reduces administrative burden and cost for both providers and payers but can also serve as the “automated handshake” between providers and payers on the best care for the patient. Leveraging its proprietary database, machine learning, AI, and other tools, Humata helps ensure that the right clinical documentation to meet payer requirements is submitted for every required prior authorization, improving first pass approvals for providers with less human touch for all parties. We are proud to be a part of Humata’s journey to help them transform the end-to-end experience of prior authorizations for payers and providers so more time and energy can be focused on patient care rather than paperwork. Read more about Humata Health’s funding announcement here: https://lnkd.in/gGzyDtAk

Mass General Brigham is the nation’s largest academic research enterprise and a leader in #Healthcare #Innovation. Over the past decade, with Chris Coburn as CIO, MGB has spun-out more than 300 companies while balancing adoption of innovation from outside its walls too. For the June episode of the #HealthcareIsHard podcast, Keith J. Figlioli interviewed Chris live on stage at #DHISeast where they discussed the unique environment for healthcare innovation right now, and so much more. Listen here: https://lnkd.in/eAdJ6pzV

💡 With over $40 billion in US public funding and billions more in private funding globally over the last 10 or so years, how much has healthcare changed despite all of this investment? Keith J. Figlioli kicked off Day 2 of DevDays with a thought-provoking keynote about the impact AI could have on global healthcare. Over 70% of healthcare executives are reporting a lack of clear ROI from digital health tech investments, which can take 5-10 years to be fully realized. But are we looking at all of this in the wrong way? Keith compares healthcare to the travel industry, which looked to get rid of a manual booking system way back in 1960 and only became a reality decades later. Healthcare is still near the beginning of its journey to digitization. So what’s next? The second wave of digital health solutions. The healthcare industry will begin to see really meaningful ROI when it is able to scale using AI to combat things like unstructured data, waste (e.g. to alleviate time and money spent on repeated admin and operational tasks), and healthcare worker burnout. What could this look like? In the short run, admin and operational use cases gain traction, such as prior auth and clinical documentation. In the long run, “frictionless” transactions between payers and providers and expanded clinical decision support. However, Keith stressed the importance of AI governance as we head down that road. What are your thoughts? Health Level Seven International #FHIRDevDays #FHIR #AI

Technology has not truly transformed #healthcare – yet – but AI-driven transformation is just beginning. Catch Keith J. Figlioli’s keynote at the #FHIRDevDays conference this week, where he’ll talk through the potential impact #AI will have on healthcare, the timeline, and what needs to happen in order to get there. He’ll be on the main stage for the opening session tomorrow, June 11.   https://lnkd.in/ef6HctBy  

Congratulations to our portfolio company, Sware, for raising its Series B, bringing its total raised since inception to $26M! This funding will accelerate life sciences innovation by automating FDA-mandated software validation.     Every time software that pharma, medical device and biotech companies use for development and manufacturing gets updated, the FDA requires it to be validated for data integrity, reliability, and patient safety. In a world filled with SaaS companies, where updates happen all the time, the manual process of validating software can add time and up to 30% more to the cost of a project. The complexity will only increase as these companies rely more on AI, which will have to be validated too.     Through its cloud-based Res_Q platform, Sware allows pharmaceutical, medical device, and biotechnology companies to automate, integrate and scale their validation processes. Res_Q is built with an open API architecture that allows organizations to control all validation processes while performing intelligent risk assessments to initiate workflows and assign workloads based on risk profile.     LRVHealth is proud to be a part of Sware's journey and to support their mission of rescuing life sciences companies from the grip of validation debt; the unpaid cost of release, testing, GxP, and business requirements. Congratulations to CEO Ellen Reilly and the entire Sware team on this milestone.     Read more about Sware's Series B funding announcement here: https://lnkd.in/eQnStqas 

Exciting news for our portfolio company Carevīve! The company has been acquired by Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations. Carevive’s flagship platform and data is used by oncology providers and life science researchers in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote monitoring, and post-treatment care. The Carevive team is deeply committed to leveraging data and analytics to improve patient care and outcomes in oncology.  Together with Health Catalyst, Carevive will be able to further its mission. Carevive CEO Bruno Lempernesse explained, “by uniting with Health Catalyst, we’re not just expanding our capabilities; we’re also enhancing our ability to make a difference. With their expertise and solutions augmenting ours, Carevive is poised to deliver even more innovative solutions to cancer centers and provide researchers with unparalleled real-world data. Together, we’re shaping a future where patient-centered care and groundbreaking research converge seamlessly.” LRVHealth has been part of Carevive’s journey since first investing in the company in 2016. We are incredibly proud of the advancements Bruno Lempernesse, Madelyn Trupkin Herzfeld and their team have made in oncology and are excited to see them continue to make a significant impact as they embark on this next chapter! If you are an entrepreneur working on innovative solutions in oncology, or know someone who is, we would love to hear from you. Please reach out to Keith J. Figlioli or Adeyoola Adeniji! Our team continues to focus on advancing oncology through innovation. Read Health Catalyst’s press release announcing the news: https://lnkd.in/epWtfk3j

The Digital Healthcare Innovation Summit kicked off yesterday in Boston with a keynote fireside chat between Keith J. Figlioli and Chris Coburn, CIO at Mass General Brigham. And the fun continues today!     Catch Josh Flum at 11:35am for a panel focused on #digitalhealth innovation and make sure to stick around for Ellen Herlacher’s interview at 2:10pm. Andrea Linna will lead the interview and they will explore executive leadership in the digital health space including best practices for setting vision, leading change, building teams, fostering innovation, incubating ideas, and balancing stakeholder expectations. Ellen will share her thoughts on what leadership looks like in venture-backed companies focused on rapid scale and innovation.    See you today for Day 2 of #DHISEast! Cambridge Innovation Institute Nandini Kashyap Benjamin Lakin, PhD